Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support

Psycho-Oncology

Volumn 8, Issue 2, 1999, Pages 167-176

  Winer, Eric P ^a,d   Lindley, Celeste ^b,c   Hardee, Melanee ^b   Sawyer, William T ^b   Brunatti, Caryn ^a   Borstelmann, Nancy A ^a   Peters, William ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; DISTRESS SYNDROME; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; SEXUAL FUNCTION; SYMPTOMATOLOGY;

ADULT; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SURVIVAL; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0032963658     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1611(199903/04)8:2<167::AID-PON354>3.0.CO;2-S     Document Type: Article

References (28)

1. Andrykowski, M.A., Altmaier, E.M., Barnett, R.L. et al. (1990) Quality of life in adult survivors of allogeneic bone marrow transplantation: correlates and comparison with matched renal transplant recipients. Transplantation 52, 399-406.
2. Antman, K., Ayash, L., Elias, A. et al. (1992) A phase II study of high dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J. Clin. Oncol. 10, 102-110.
3. Antman, K.S., Armitage, J.O., Horowitz, M.M. et al. (1994) Autotransplants for breast cancer in North America. Proc. Am. Soc. Clin. Oncol. 13, 67 (abstract).
4. Baker, F., Wingard, J.R., Curbow, B. et al. (1994) Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant. 13, 589-596.
5. Belec, R.H. (1992) Quality of life - perceptions of long-term survivors of bone marrow transplantation. Oncol. Nurs. Forum 19, 31-37.
6. Bezwoda, W.R., Seymour, L. and Dansey, R.D. (1995) High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial. J. Clin. Oncol. 13, 2483-2489.
7. Bush, N., Haberman, M., Donaldson, G. and Sullivan, K.L. (1995) Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc. Sci. Med. 40, 479-490.
8. Cella, D.F. and Tulsky, D.S. (1990) Measuring quality of life today: methodological aspects. Oncology 4, 29-38.
9. Chao, N.J., Tierney, K., Bloom, J.R. et al. (1992) Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 80, 825-830.
10. Dunphy, F.R., Spitzer, G., Buzdar, A.U. et al. (1990) Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support. J. Clin. Oncol. 8, 1207-1216.
11. Ferrell, B., Grant, M., Shmidt, G.M. et al. (1992) The meaning of quality of life for bone marrow transplant survivors: part 1 - the impact of bone marrow transplant on quality of life. Cancer Nurs. 15, 153-160.
12. Haberman, M., Bush, N., Young, K. and Sullivan, K. (1993) Quality of life of adult long-term survivors of bone marrow transplantation: a qualitative analysis of narrative data. Oncol. Nurs. Forum 20, 1545-1553.
13. Hann, D.M., Jacobsen, P.B., Martin, S.C., Kronish, L.E., Azzarello, L.M. and Fields, K.K. (1997) Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplant. 19, 257-264.
14. Kornblith, A.B., Anderson, J., Cella, D.F., Tross, S., Zuckerman, E., Cherin, E. et al. (1990) Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials. Oncology 4, 93-101.
15. Lindley, C.M., Hirsch, J.D., O'Neill, C.V. et al. (1992) Quality of life consequences of chemotherapy-induced emesis. Quality of Life Research 1, 331-340.
16. Livingston, R, Collins, C., Thompson, T. et al. (1993) High-dose cyclophosphamide, etoposide, and cisplatin (CEP) consolidation for stage 4 breast cancer. Proc. Am. Soc. Clin. Oncol. 12, 62 (abstract).
17. McCorkle, L.R. and Lopez, M. (1983) PAIS and PAIS-SR Administration, Scoring And Procedures Manual-1. Clinical Psychometrics Research, Baltimore.
18. McCorkle, L.R. and Lopez, M. (1994) PAIS and PAIS-SR Administration, Scoring And Procedures Manual-1. Clinical Psychometrics Research, Baltimore.
19. McQuellon, R.P., Craven, B., Russell, G.B., Hoffman, S., Cruz, J.M. et al. (1996) Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant. 18, 579-584.
20. Moinpour, C.M., Feigl, P., Metch, B. et al. (1989) Quality of life endpoints in cancer clinical trials: reviews and recommendations. J. Natl. Cancer Inst. 81, 485-495.
21. Mumma, G.H., Mashberg, D. and Lesko, L.M. (1992) Long-term psychosexual adjustment of acute leukemia survivors: impact of marrow transplantation versus conventional chemotherapy. Gen Hosp Psychiatry 14, 43-55.
22. Peters, W.P., Ross, M., Vredenburgh, J. et al. (1992) High-dose alkylating agents and autologous bone marrow support (ABMT) for stage II/III breast cancer involving 10 or more axillary lymph nodes. Proc. Am. Soc. Clin. Oncol. 11, 58 (abstract).
23. Peters, W.P., Ross, M., Vredenburgh, J. et al. (1993) High-dose adjuvant chemotherapy with autologous bone marrow support as consolidation after standard dose adjuvant therapy for high-risk primary breast cancer. J. Clin. Oncol. 11, 1132-1143.
24. Schag, C.C. and Heinrich, R.L. (1988) CARES: Cancer Rehabilitation Evaluation System. Cares Consultants, Los Angeles.
25. Schipper, H., Clinch, J., McMurray, A. et al. (1984) Measuring the quality of life of cancer patients: the Functional Living Index - Cancer: development and validation. J. Clin. Oncol. 2, 472-483.
26. Vose, J.M., Kennedy, B.C., Bierman, P.J. et al. (1992) Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 69, 784-789.
27. Winer, E.P., Gold, D.T., Lees, J. et al. (1991) Quality of life (QOL) following high dose chemotherapy with autologous bone marrow support (HDC) in patients with metastatic breast cancer. Proc. Am. Soc. Clin. Oncol. 10, 62 (abstract).
28. Winer, E.P. and Sutton, L.M. (1994) Quality of life after bone marrow transplantation. Oncology 8, 19-27.